Form 8-K - Current report:
SEC Accession No. 0000950170-22-000038
Filing Date
2022-01-04
Accepted
2022-01-04 16:32:11
Documents
14
Period of Report
2021-12-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxst-20211229.htm   iXBRL 8-K 59478
2 EX-99.1 rxst-ex99_1.htm EX-99.1 14649
3 GRAPHIC img261313502_0.jpg GRAPHIC 4493
  Complete submission text file 0000950170-22-000038.txt   204201

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxst-20211229.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxst-20211229_pre.xml EX-101.PRE 9830
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxst-20211229_lab.xml EX-101.LAB 13342
8 EXTRACTED XBRL INSTANCE DOCUMENT rxst-20211229_htm.xml XML 4686
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 22506556
SIC: 3851 Ophthalmic Goods